

कृपया अन्य खोज का प्रयास करें
चिन्ह | एक्सचेंज | करेंसी | ||
---|---|---|---|---|
LUPN | NSE | INR | रियल टाइम | |
LUPNc1:NS | NSE | INR | देरी | |
LUPNc2:NS | NSE | INR | देरी | |
LUPNc3:NS | NSE | INR | देरी | |
LUPN | BSE | INR | देरी |
Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India and internationally. It engages in the drug discovery, development, production, marketing, and sale of various branded and generic formulations, biosimilars, over-the-counter and specialty drugs, and active pharmaceutical ingredients (APIs). The company offers formulations for use in the therapeutic areas of anti-tuberculosis, diabetes management, cardiovascular, chronic obstructive pulmonary diseases, asthma, gynecology and women’s health, central nervous system, oncology, immunology, genomics, metabolic disorders, dermatology, urology, pediatrics, gastrointestinal, anti-infective, and nonsteroidal anti-inflammatory drug therapies, as well as engages in the bio clinical research activities. It operates through network consists of labs, LupiMitra collection centers, and pick-up points. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Manju Deshbandhu Gupta | 77 | 2017 | Non-Executive Chairman of the Board |
Vinita D. Gupta | 53 | 2003 | CEO & Executive Director |
Jean-Luc Belingard | 74 | 2015 | Independent Non-Executive Director |
Punita Kumar-Sinha | 60 | 2020 | Independent Director |
Kanwar Bir Singh Anand | 67 | 2020 | Independent Director |
Mark D. McDade | 68 | 2021 | Independent Director |
Nilesh Deshbandhu Gupta | - | 2006 | MD & Executive Director |
Ramesh Swaminathan | 58 | 2007 | Executive Director, Global CFO, CRO & Head of API Plus SBU |
Alfonso G. Zulueta | 61 | 2024 | Independent Director |
Jeffrey Kindler | 69 | 2024 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है